While the precise pathogenesis of AD remains elusive, research indicates that key pathological features include the accumulation of extracellular amyloid-beta (Aβ) plaques, abnormal tau phosphorylation and aggregation, neuroinflammation, and various metabolic disruptions, such as impaired glucose metabolism and mitochondrial dysfunction. The gene discussed is MAPT; the disease is Alzheimer disease.